Prevalence of subnormal testosterone concentrations in men with type 2 diabetes and chronic kidney disease

European Journal of Endocrinology

Volumn 173, Issue 3, 2015, Pages 359-366

  Dhindsa, Sandeep ^a   Reddy, Anand ^a,b   Karam, Jyotheen Sukhmoy ^c   Bilkis, Sayeeda ^a   Chaurasia, Archana ^b   Mehta, Aditya ^d   Raja, Keerthi P ^b   Batra, Manav ^d   Dandona, Paresh ^d  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Permian Basin Kidney Center   (United States)

^c Nephrology Asso   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADOTROPIN; HEMOGLOBIN; INSULIN; LUTEINIZING HORMONE; METFORMIN; PROLACTIN; SEX HORMONE BINDING GLOBULIN; SULFONYLUREA; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLITROPIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GONADOTROPIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; KIDNEY FAILURE; LIQUID CHROMATOGRAPHY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL; AGED; BLOOD; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; HYPOGONADISM; METABOLISM; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY;

AGED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; FOLLICLE STIMULATING HORMONE; GLOMERULAR FILTRATION RATE; HUMANS; HYPOGONADISM; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PREVALENCE; PROLACTIN; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN; TANDEM MASS SPECTROMETRY; TESTOSTERONE;

EID: 84940705590     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0359     Document Type: Article

References (37)

1. Dandona P & Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. Journal of Clinical Endocrinology and Metabolism 2011 96 2643-2651. (doi:10.1210/jc.2010-2724)
2. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A & Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2004 89 5462-5468. (doi:10.1210/jc.2004-0804)
3. Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A & Dandona P. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care 2010 33 1186-1192. (doi:10.2337/dc09-1649)
4. Chandel A, Dhindsa S, Topiwala S, Chaudhuri A & Dandona P. Testosterone concentration in young patients with diabetes. Diabetes Care 2008 31 2013-2017. (doi:10.2337/dc08-0851)
5. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS & Montori VM. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 2536-2559. (doi:10.1210/jc.2009-2354)
6. Kapoor D, Aldred H, Clark S, Channer KS & Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 2007 30 911-917. (doi:10.2337/dc06-1426)
7. USRDS 2014 United States Renal Data System. Annual Data Report, Chapter 1: CKD in the General Population, Page 17. www.usrds.org.
8. Handelsman DJ. Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation. Endocrine Reviews 1985 6 151-182. (doi:10.1210/edrv-6-2-151)
9. de Vries CP, Gooren LJ & Oe PL. Haemodialysis and testicular function. International Journal of Andrology 1984 7 97-103. (doi:10.1111/j.1365-2605.1984.tb00765.x)
10. Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A et al. Endogenous testosterone, endothelial dysfunction cardiovascular events in men with nondialysis chronic kidney disease. Clinical Journal of the American Society of Nephrology 2011 6 1617-1625. (doi:10.2215/CJN.10681210)
11. Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV Jr & Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. American Journal of Kidney Diseases 2014 64 367-374. (doi:10.1053/j.ajkd.2014.03.010)
12. Bello AK, Stenvinkel P, Lin M, Hemmelgarn B, Thadhani R, Klarenbach S, Chan C, Zimmerman D, Cembrowski G, Strippoli G et al. Serum testosterone levels and clinical outcomes in male hemodialysis patients. American Journal of Kidney Diseases 2014 63 268-275. (doi:10.1053/j.ajkd.2013.06.010)
13. Carrero JJ, Qureshi AR, Nakashima A, Arver S, Parini P, Lindholm B, Barany P, Heimburger O & Stenvinkel P. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrology, Dialysis, Transplantation 2011 26 184-190. (doi:10.1093/ndt/gfq397)
14. Salameh WA, Redor-Goldman MM, Clarke NJ, Reitz RE & Caulfield MP. Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges. Steroids 2010 75 169-175. (doi:10.1016/j.steroids. 2009.11.004)
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AFIII, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T et al. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 2009 150 604-612. (doi:10.7326/0003-4819-150-9-200905050-00006)
16. Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. Journal of Clinical Endocrinology and Metabolism 2010 95 1810-1818. (doi:10.1210/jc.2009-1796)
17. Eckersten D, Giwercman A & Christensson A. Male patients with terminal renal failure exhibit low serum levels of antimullerian hormone. Asian Journal of Andrology 2015 17 149-153. (doi:10.4103/1008-682X.135124)
18. Molsted S, Andersen JL, Eidemak I, Harrison AP & Jorgensen N. Resistance training and testosterone levels in male patients with chronic kidney disease undergoing dialysis. BioMed Research International 2014 2014 121273. (doi:10.1155/2014/121273)
19. Albaaj F, Sivalingham M, Haynes P, McKinnon G, Foley RN, Waldek S, O'Donoghue DJ & Kalra PA. Prevalence of hypogonadism in male patients with renal failure. Postgraduate Medical Journal 2006 82 693-696. (doi:10.1136/pgmj.2006.045963)
20. Veldhuis JD, Wilkowski MJ, Zwart AD, Urban RJ, Lizarralde G, Iranmanesh A & Bolton WK. Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. Journal of Clinical Endocrinology and Metabolism 1993 76 648-654. (doi:10.1210/jcem.76.3.8445020)
21. Schaefer F, Veldhuis JD, Robertson WR, Dunger D & Scharer K. Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. Kidney International 1994 45 1465-1476. (doi:10.1038/ki.1994.191)
22. Mitchell R, Bauerfeld C, Schaefer F, Scharer K & Robertson WR. Less acidic forms of luteinizing hormone are associated with lower testosterone secretion in men on haemodialysis treatment. Clinical Endocrinology 1994 41 65-73. (doi:10.1111/j.1365-2265. 1994.tb03786.x)
23. Handelsman DJ, Spaliviero JA & Turtle JR. Bioactive luteinizing hormone in plasma of uraemic men and men with primary testicular damage. Clinical Endocrinology 1986 24 259-266. (doi:10.1111/j.1365-2265.1986.tb03266.x)
24. Katz AI & Emmanouel DS.Metabolism of polypeptide hormones by the normal kidney and in uremia. Nephron 1978 22 69-80. (doi:10.1159/000181425)
25. Yavuz D, Topcu G, Ozener C, Akalin S & Sirikci O. Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy. Clinical Endocrinology 2005 63 520-524. (doi:10.1111/j.1365-2265.2005.02375.x)
26. Veldhuis JD, Iranmanesh A, Wilkowski MJ & Samojlik E. Neuroendocrine alterations in the somatotropic and lactotropic axes in uremic men. European Journal of Endocrinology 1994 131 489-498. (doi:10.1530/eje.0.1310489)
27. Singh AB, Norris K, Modi N, Sinha-Hikim I, Shen R, Davidson T & Bhasin S. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. Journal of Clinical Endocrinology and Metabolism 2001 86 2437-2445. (doi:10.1210/jc.86.6.2437)
28. Kyriazis J, Tzanakis I, Stylianou K, Katsipi I, Moisiadis D, Papadaki A, Mavroeidi V, Kagia S, Karkavitsas N & Daphnis E. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrology, Dialysis, Transplantation 2011 26 2971-2977. (doi:10.1093/ndt/gfq847)
29. Grossmann M, Hoermann R, Ng Tang Fui M, Zajac JD, Ierino FL & Roberts MA. Sex steroids levels in chronic kidney disease and kidney transplant recipients: associations with disease severity and prediction of mortality. Clinical Endocrinology 2014 82 767-775. (doi:10.1111/cen. 12656)
30. Bhatia V, Chaudhuri A, Tomar R, Dhindsa S, Ghanim H & Dandona P. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care 2006 29 2289-2294. (doi:10.2337/dc06-0637)
31. Carrero JJ, Barany P, Yilmaz MI, Qureshi AR, Sonmez A, Heimburger O, Ozgurtas T, Yenicesu M, Lindholm B & Stenvinkel P. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease. Nephrology, Dialysis, Transplantation 2012 27 709-715. (doi:10.1093/ndt/gfr288)
32. Yang Q, Abudou M, Xie XS & Wu T. Androgens for the anaemia of chronic kidney disease in adults. Cochrane Database of Systematic Reviews 2014 10 CD006881. (doi:10.1002/14651858.cd006881.pub2)
33. Brockenbrough AT, Dittrich MO, Page ST, Smith T, Stivelman JC & Bremner WJ. Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease. American Journal of Kidney Diseases 2006 47 251-262. (doi:10.1053/j.ajkd.2005.10.022)
34. El-Assmy A. Erectile dysfunction in hemodialysis: a systematic review. World Journal of Nephrology 2012 1 160-165. (doi:10.5527/wjn.v1.i6.160)
35. Yavuz D, Acar FN, Yavuz R, Canoz MB, Altunoglu A, Sezer S & Durukan E. Male sexual function in patients receiving different types of renal replacement therapy. Transplantation Proceedings 2013 45 3494-3497. (doi:10.1016/j.transproceed.2013.09.025)
36. Park MG, Koo HS & Lee B. Characteristics of testosterone deficiency syndrome in men with chronic kidney disease and male renal transplant recipients: a cross-sectional study. Transplantation Proceedings 2013 45 2970-2974. (doi:10.1016/j.transproceed.2013.08.087)
37. Carrero JJ. Testosterone deficiency at the crossroads of cardiometabolic complications in CKD. American Journal of Kidney Diseases 2014 64 322-325. (doi:10.1053/j.ajkd.2014.06.002)